HITLAB BLOG

NATO Announces Sana Health as winner of the NATO Innovation Challenge

In preparation for the NATO competition, Sana worked with a group of digital health scientists from HITLAB, one of the world’s preeminent digital health testing labs, in New York City to launch a rapid pilot study to investigate the device’s efficacy with fatigue mitigation. Late last month Sana completed a successful 24hr fatigue mitigation study with HITLAB, led by Prof. Stan Kachnowski, Director of the Digital Health Certification Program at Columbia Business School Executive Education.

Full Press Release

NATO – Chiefs of Transformation Conference, Norfolk VA, Wednesday December 12th, 2019.

The modern war-fighter faces increasing cognitive demands, exponentially more information, and a greater need for mental resilience than ever before. Sana, a device that uses audiovisual neuromodulation to produce a deep state of relaxation and optimize recovery, was chosen as the most promising technology to help address this growing need.

Sana is a wearable device that guides the user into a state of relaxation in just 10 minutes. In addition to the immediate relaxation effects, the device helps return the brain to optimum brainwave states over time. This has applications across pain, addiction, anxiety and sleep problems. Given the state of the opioid crisis and the market effects of this catastrophe, this discovery has huge implications.

Richard Hanbury, Founder and CEO of Sana, originally developed the earliest prototype after a jeep crash in Yemen in 1992 left him in severe, chronic pain and a 5-year life expectancy. The earliest prototype wiped out all of his nerve damage pain and saved his life.

Since then, Hanbury and Sana have been on a mission to bring this technology to the world and to help the millions of people in need of non-drug solutions to reduce pain, facilitate sleep, diminish anxiety, and eliminate addiction.

Sana has completed ground-breaking clinical trials in Opioid Use Disorder (OUD), fibromyalgia with third-party verification of top experts in each field. In patients with fibromyalgia, Sana outperformed the top-marketed drugs for addressing symptoms of depression, anxiety and sleep disorders.

A Telemedicine Intervention for Hospital Case Management
Faced with declining budgets, hospitals and trauma centers are increasingly pressured to find innovative solutions that allocate scare resources while effectively improving care quality. Do mobile health technologies hold the potential to address these challenges?
Read More

Whilst these are small trials, the early signs are exceptional. Sana is following up with larger-scale studies, including a 3-month investigation in patients with neuropathic pain with Dr. David Putrino at Mount Sinai, a Multiple Sclerosis study in the final planning stages at the Cleveland Clinic, and a post-operative pain study being planned at the University of Pennsylvania. Sana has applied to the FDA for a de novo clearance for fibromyalgia and hopes to be on market early in 2020.

In preparation for the NATO competition, Sana worked with a group of digital health scientists from HITLAB, one of the world’s preeminent digital health testing labs, in New York City to launch a rapid pilot study to investigate the device’s efficacy with fatigue mitigation. Late last month Sana completed a successful 24hr fatigue mitigation study with HITLAB, led by Prof. Stan Kachnowski, Director of the Digital Health Certification Program at Columbia Business School Executive Education.

A briefing of the results from this study can be found at www.hitlab.org/sanastudy

With the recent wins at UCSF Digital Health Awards, Anthem, and NATO Innovation Summit, Sana is collecting more and more evidence that it is a highly effect non-pharmacological treatment for chronic pain, anxiety, and addiction, and should be in every physicians’ toolkit to help patients.

Explore Articles

The Verdict Is In: Digital Health Interventions Succeeded in the Age of COVID-19

Digital health interventions (DHIs) are health services delivered electronically through formal or informal care. DHIs can be used for a wide range of services such as facilitated health promotion communication, electronic medical records used by providers, or mobile health apps used by consumers. Ultimately, DHIs are used to achieve certain health objectives. During the COVID-19 outbreak, digital health interventions began to gain popularity and attention, as it offered solutions to pressing healthcare issues caused by the pandemic. In a HITLAB (Health Innovation Technologies Lab) Virtual Town Hall presented by Information Mediary Corp. (IMC), a group of expert panelists, discussed the importance of digital health interventions for patients and physicians in the age of COVID-19.  

Spring 2022 Breakthrough Finalists Announced

New York, NY, USA. On Thursday, May 26th, HITLAB hosted its May Digital Symposium focused on leveraging technology for women’s and mental health. The event is sponsored by Vicert. The virtual symposium featured 3 hours of thought-provoking content with 12+ sessions covering current major topics in women’s and mental health including…

Telehealth in the Postpandemic Era

COVID-19 has forever changed our lives in many ways including the now wide-spread adoption of new medical technologies and practices such as telemedicine for non-emergency care.